Bell's palsy following the Ad26.COV2.S COVID-19 vaccination

被引：16
|
作者：
Nishizawa, Y. [1 ]
Hoshina, Y. [1 ]
Baker, V [1 ]
机构：
[1] US Naval Hosp Yokosuka, Dept Neurol, 82 Inaoka Cho, Yokosuka, Kanagawa 2380001, Japan
来源：
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE | 2021年 / 114卷 / 09期
关键词：
D O I：
10.1093/qjmed/hcab143
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：657 / 658
页数：2
相关论文
共 50 条
  • [41] Association of Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barre Syndrome Reply
    Woo, Emily Jane
    Dimova, Rositsa B.
    Mba-Jonas, Adamma
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (04): : 393 - 394
  • [42] Guillain-Barre Syndrome After Ad26.COV2.S Vaccination
    Thant, Hein Linn
    Morgan, Richard
    Paese, Mario M.
    Persaud, Trevor
    Diaz, Jose
    Hurtado, Lina
    AMERICAN JOURNAL OF CASE REPORTS, 2022, 23
  • [43] Preliminary Analysis of the Effects of Ad26.COV2.S Vaccination on CT Findings and High Intensive Care Admission Rates of COVID-19 Patients
    Negroni, Davide
    Carriero, Serena
    Passarella, Ilaria
    Siani, Agnese
    Biondetti, Pierpaolo
    Pizzolante, Antonio
    Saba, Luca
    Guzzardi, Giuseppe
    TOMOGRAPHY, 2022, 8 (05) : 2403 - 2410
  • [44] Age- and Sex-Specific Incidence of Cerebral Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination
    Ashrani, Aneel A.
    Crusan, Daniel J.
    Petterson, Tanya
    Bailey, Kent
    Heit, John A.
    JAMA INTERNAL MEDICINE, 2022, 182 (01) : 80 - 83
  • [45] Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
    Marcel Kemper
    Christoph Berssenbrügge
    Georg Lenz
    Rolf Michael Mesters
    Annals of Hematology, 2022, 101 : 927 - 928
  • [46] Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
    Kemper, Marcel
    Berssenbruegge, Christoph
    Lenz, Georg
    Mesters, Rolf Michael
    ANNALS OF HEMATOLOGY, 2022, 101 (04) : 927 - 928
  • [47] Comment on "Oral lichen planus following the administration of vector based COVID-19 vaccine (Ad26.COV2.S)". Authors' reply
    Troeltzsch, Matthias
    Berndt, Ronald
    Troeltzsch, Markus
    ORAL DISEASES, 2022, 28 : 2610 - 2611
  • [48] The association between COVID-19 vaccination and Bell's palsy Comment
    Cirillo, Nicola
    Doan, Richard
    LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 5 - 6
  • [49] Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16-17 Years of Age
    Ruiz-Guinazu, Javier
    Le Gars, Mathieu
    Cardenas, Vicky
    Vaissiere, Nathalie
    Sadoff, Jerald
    Truyers, Carla
    Hendriks, Jenny
    Scheper, Gert
    de Groot, A. Marit
    Struyf, Frank
    Schuitemaker, Hanneke
    Douoguih, Macaya
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2024, 13 (11) : 599 - 601
  • [50] Ad26.COV2.S: safety and efficiency data
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Ruelle, Yannick
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (175): : 336 - 336
12345